MetaADEDB 2.0 @ LMMD
Amikacin
(FXKSEJFHKVNEFI-GCZBSULCSA-N)
Structure
SMILES
OS(=O)(=O)O.OS(=O)(=O)O.NCC[C@@H](C(=O)N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1O[C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)N)O)O)O[C@H]1O[C@H](CN)[C@H]([C@@H]([C@H]1O)O)O)O
Molecular Formula:
C22H47N5O21S2
Molecular Weight:
781.759
Log P:
-4.3761
Hydrogen Bond Acceptor:
26
Hydrogen Bond Donor:
17
TPSA:
497.9
CAS Number(s):
39831-55-5
Synonym(s)
1.
Amikacin
2.
A.M.K
3.
Amikacin Sulfate
4.
Amikacina Medical
5.
Amikacina Normon
6.
Amikafur
7.
Amikalem
8.
Amikason's
9.
Amikayect
10.
Amikin
11.
Amiklin
12.
Amukin
13.
BB-K 8
14.
BB-K8
15.
Biclin
16.
Biklin
17.
Gamikal
18.
Kanbine
19.
Oprad
20.
Yectamid
21.
BB K 8
22.
BB K8
23.
BBK 8
24.
BBK8
25.
Medical, Amikacina
26.
Normon, Amikacina
27.
Sulfate, Amikacin
External Link(s)
MeSHD000583
PubChem Compound25010735
38351
44659004
ChEBI2638
CHEMBLCHEMBL4208954
KEGGdr:D00865
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1TinnitusFAERS: 3US FAERS
2Acute kidney injuryFAERS: 2US FAERS
3DeafnessFAERS: 2US FAERS
4General physical health deteriorationFAERS: 2US FAERS
5Medication ErrorFAERS: 2US FAERS
6Accidental exposure to product by childFAERS: 1US FAERS
7Accidental overdoseFAERS: 1US FAERS
8Acute respiratory failureFAERS: 1US FAERS
9Altered state of consciousnessFAERS: 1US FAERS
10AmaurosisFAERS: 1US FAERS
11AnuriaFAERS: 1US FAERS
12Back PainFAERS: 1US FAERS
13Bronchopulmonary AspergillosisFAERS: 1US FAERS
14Burning sensationFAERS: 1US FAERS
15Cardiac ArrestFAERS: 1US FAERS
16DehydrationFAERS: 1US FAERS
17DysarthriaFAERS: 1US FAERS
18Ear discomfortFAERS: 1US FAERS
19ExophthalmosFAERS: 1US FAERS
20Febrile NeutropeniaFAERS: 1US FAERS
21HeadacheFAERS: 1US FAERS
22HemiparesisFAERS: 1US FAERS
23Hepatosplenic candidiasisFAERS: 1US FAERS
24Incorrect route of drug administrationFAERS: 1US FAERS
25Injection site phlebitisFAERS: 1US FAERS
26Leukocytoclastic vasculitisFAERS: 1US FAERS
27NauseaFAERS: 1US FAERS
28Neutropenic colitisFAERS: 1US FAERS
29Peritonsillar AbscessFAERS: 1US FAERS
30Pleuritic painFAERS: 1US FAERS
31PneumoniaFAERS: 1US FAERS
32PolyuriaFAERS: 1US FAERS
33Respiratory arrestFAERS: 1US FAERS
34Respiratory tract irritationFAERS: 1US FAERS
35Scedosporium infectionFAERS: 1US FAERS
36SinusitisFAERS: 1US FAERS
37SomnolenceFAERS: 1US FAERS
38Stevens-Johnson SyndromeFAERS: 1US FAERS
39TetanyFAERS: 1US FAERS
40ThrombocytopeniaFAERS: 1US FAERS
41TonsillitisFAERS: 1US FAERS
42VasculitisFAERS: 1US FAERS
43VomitingFAERS: 1US FAERS
44Blood creatinine increasedCanada Vigilance: 2Canada Vigilance
45Drug level increasedCanada Vigilance: 1Canada Vigilance
46OtotoxicityCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.